Following primary extraction, cannabinoid intermediates undergo a series of controlled purification and physical refinement processes designed to produce pharmaceutical-grade active substances.
These downstream operations include multi-stage purification, molecular distillation, and crystallisation techniques that enable the selective isolation of defined cannabinoid compounds.
Through careful process control and analytical verification, we can adjust purity profiles, cannabinoid concentration, and physical characteristics to meet specific downstream pharmaceutical development or manufacturing requirements.
Our purification strategies are designed to support:
- Production of defined cannabinoid APIs
- Consistent batch-to-batch quality
- Removal of process impurities and unwanted plant constituents
- Alignment with pharmaceutical quality standards
These processes form a critical bridge between plant-derived raw material and cannabinoid active pharmaceutical ingredients suitable for further pharmaceutical development.
